Finding and managing cases of latent TB infection (LTBI) is a critical element of TB control and prevention. 1 Th e US Centers for Disease Control and Prevention (CDC) recommend that in low-incidence settings, TB control programs conduct cohort reviews on patients with LTBI to enhance program quality. 2 However, although the methods of cohort review for TB disease are well established, 3 methods for implementing LTBI cohort reviews have not yet been established or reported in the literature. We report the design and implementation of a cohort review for LTBI in the low-incidence setting of the US Army.
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To the Editor:
Finding and managing cases of latent TB infection (LTBI) is a critical element of TB control and prevention. 1 Th e US Centers for Disease Control and Prevention (CDC) recommend that in low-incidence settings, TB control programs conduct cohort reviews on patients with LTBI to enhance program quality. 2 However, although the methods of cohort review for TB disease are well established, 3 methods for implementing LTBI cohort reviews have not yet been established or reported in the literature. We report the design and implementation of a cohort review for LTBI in the low-incidence setting of the US Army.
The methods used for the LTBI cohort review were developed and modified from those described previously by the CDC for TB disease. 3 The data collection instrument was modified from that used by the CDC, including demographics; clinical, radiographic, and laboratory case characteristics; deployment and travel history; and treatment adherence and other outcomes. A stratified random sample of LTBI cases was selected from three heterogeneous US Army installations.
Two hundred ninety-four TB tests were performed on the 215 subjects at time of evaluation. Th e top three reasons for testing were deployment (38%), accession (24%), and confi rmatory testing (21%). Table 1 compares treatment indicators with performance targets. Of the 194 in whom LTBI was diagnosed, 146 (75%) initiated therapy. Completion of therapy was good (78%) once initiated, but unnecessary delays in treatment initiation occurred because of provider deferral, particularly at time of entry into military service. Most testing (93%) was done among low-risk subjects despite CDC and US Department of Defense guidelines discouraging this. 4 , 5 Most of the tests (76%) performed to "confi rm" a positive test were also positive but led to average delays in treatment of 1.7 years. Deferral led to worse treatment outcomes both in completion of therapy and time to treatment. Despite the availability of an electronic TB registry, data quality did not meet performance targets. Th is cohort review suggested that TB control in the US military can be improved by (1) reducing overtesting, (2) increasing completion of LTBI treatment, (3) reducing treatment delays, and (4) ensuring data accuracy. As the incidence of TB declines in the United States, more cities, counties, and states will become low-incidence settings. Th is report describes a method of operationalizing this type of cohort review. Like the cohort review for TB disease, program improvement will only be achieved through accountability and continued action based on the fi ndings of program outcomes.
